Sampo Oyj Result Of Sampo s Sale Of Nordea Shares morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
NSE-BSE bulk deals: Societe Generale buys stake in Lodha; BofA picks up PVR shares
SECTIONS
Last Updated: May 17, 2021, 08:34 PM IST
Share
Synopsis
Segantii India Mauritius sold 318,990 shares of Macrotech at Rs 641.4 apiece through a block deal on the BSE.
Agencies BofA Securities Europe bought 349,108 shares of PVR at Rs 1,169.2 apiece through a bulk deal on the National Stock Exchange.
Related
NSE
Lodha) at Rs 641.5 per share through a block deal on the BSE.
In another transaction, Segantii India Mauritius sold 318,990 shares of Macrotech at Rs 641.4 apiece through a block deal on the BSE.
Shares of Macrotech Developers ended 0.2 per cent higher at Rs 648.2 on the BSE.
Dana Prices €325 Million Senior Notes Offering
News provided by
Share this article
Share this article
MAUMEE, Ohio, May 14, 2021 /PRNewswire/ Dana Incorporated (NYSE: DAN) ( Dana ) today announced that its wholly-owned subsidiary, Dana Financing Luxembourg S.à r.l., has priced its offering of €325 million aggregate principal amount of 3.000% Senior Notes due 2029 (the 2029 Notes ). The 2029 Notes will be fully and unconditionally guaranteed by Dana.
The company intends to allocate the net proceeds from the offering, together with cash on hand, to (i) redeem all of Dana s outstanding 6.500% Senior Notes due 2026 and (ii) pay related fees and expenses.
Credit Suisse Securities (Europe) Limited, J.P. Morgan Securities plc, Bank of Montreal, London Branch, Barclays Bank PLC, BofA Securities Europe SA, Citigroup Global Markets Limited, Goldman Sachs International, Mizuho Securities Europe GmbH, RBC Capital Markets, LLC, are acting as joint book-running managers in the
SYNLAB sets final offer price for IPO at EUR 18.00 per share
Search jobs
DGAP-News: Synlab AG / Key word(s): IPO
27.04.2021 / 22:50
Total offer volume of EUR 772 million, assuming full exercise of Greenshoe option
Offer price implies a total market capitalisation of EUR 4 billion and a total enterprise value of EUR 5.9 billion
Free float expected to amount to 19% of outstanding share capital, if Greenshoe option is fully exercised
First day of trading on the Regulated Market (Prime Standard) of the Frankfurt Stock Exchange under the trading symbol SYAB is planned for Friday, 30 April 2021
SYNLAB (the Company ), the largest European clinical laboratory and medical diagnostic services company, has set the final offer price for its initial public offering (the Offering ) at EUR 18.00 per share. Assuming full exercise of the Greenshoe option and based on the final offer price, the total offer volume amounts to EUR 772 million. This comprises gross primary proceeds of EU
Disclaimer
This release is not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada or Japan. It does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Australia, Canada or Japan. The shares mentioned herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the Securities Act ). The shares may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements of the Securities Act. There will be no public offer of shares of SYNLAB AG (the Company ) in the United States.